The FDA “Black Box” Warning on Antidepressant Suicide Risk in Young Adults: More Harm Than Benefits?
The decision made in the year 2004 by the U.S. Food and Drug Administration (FDA) to require a boxed warning on antidepressants regarding the risk of suicidality in young adults still represents a matter of controversy. The FDA warning was grounded on industry-sponsored trials carried one decade ago...
Main Authors: | Michele Fornaro, Annalisa Anastasia, Alessandro Valchera, Alessandro Carano, Laura Orsolini, Federica Vellante, Gabriella Rapini, Luigi Olivieri, Serena Di Natale, Giampaolo Perna, Giovanni Martinotti, Massimo Di Giannantonio, Domenico De Berardis |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-05-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fpsyt.2019.00294/full |
Similar Items
-
Alexithymia and Suicide Risk in Psychiatric Disorders: A Mini-Review
by: Domenico De Berardis, et al.
Published: (2017-08-01) -
Adjunctive vortioxetine for SSRI-resistant major depressive disorder: a “real-world” chart review study
by: Domenico De Berardis, et al. -
Religious Coping, Hopelessness, and Suicide Ideation in Subjects with First-Episode Major Depression: An Exploratory Study in the Real World Clinical Practice
by: Domenico De Berardis, et al.
Published: (2020-11-01) -
Suicide During Perinatal Period: Epidemiology, Risk Factors and Clinical Correlates
by: Laura Orsolini, et al.
Published: (2016-08-01) -
Alexithymia, responsibility attitudes and suicide ideation among outpatients with obsessive-compulsive disorder: An exploratory study
by: Domenico De Berardis, et al.
Published: (2015-04-01)